Featured Research

from universities, journals, and other organizations

Predicting Premature Birth

Date:
April 18, 2007
Source:
American Chemical Society
Summary:
With pre-term births a major international health problem, scientists are reporting an advance toward developing a much-needed, noninvasive test for predicting when pregnant women are about to deliver early.

With pre-term births a major international health problem, scientists are reporting an advance toward developing a much-needed, noninvasive test for predicting when pregnant women are about to deliver early.

Oregon Health Science University’s Srinivasa R. Nagalla and colleagues there and at the University of Washington in Seattle, report the discovery of protein biomarkers that could lead to such a test. The work is reported in the April 9 issue of ACS’ Journal of Proteome Research, a monthly publication.

In the report, researchers explain that spontaneous preterm births (before 37 weeks of pregnancy) have increased steadily during the last 25 years and now account for 70 percent to 80 percent of neonatal deaths. Development of a rapid diagnostic test for pre-term labor thus would be a major advance, they added.

The researchers analyzed cervical-vaginal fluid from 18 women, including six with spontaneous preterm birth, six with preterm labor, and six controls. They identified proteins that were present in women with preterm deliveries that could eventually serve as biomarkers for the condition. While emphasizing that the finding should be confirmed in a larger group of women, the study terms it an important step toward identifying women at high risk for preterm birth.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Predicting Premature Birth." ScienceDaily. ScienceDaily, 18 April 2007. <www.sciencedaily.com/releases/2007/04/070416095359.htm>.
American Chemical Society. (2007, April 18). Predicting Premature Birth. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/04/070416095359.htm
American Chemical Society. "Predicting Premature Birth." ScienceDaily. www.sciencedaily.com/releases/2007/04/070416095359.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins